Although the elevation of ALT and AST levels similarly occurred in all patients with COVID-19, the prevalence of elevated AST is often higher than ALT in severe COVID-19,47 which was different from the findings of Marjot et al.,48 reporting a classic hepatocellular pattern of liver injury. The gene discussed is GPT; the disease is COVID-19.